← Back to Search

Vasodilator

inhaled nitric oxide for Cardiac Arrest

Phase < 1
Waitlist Available
Led By Jignesh K Patel, MD
Research Sponsored by Stony Brook University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up upto 24 weeks
Awards & highlights

Study Summary

This trial will test whether inhaling nitric oxide can improve resuscitation from cardiac arrest and improve short-term survival and neurologic outcome.

Eligible Conditions
  • Cardiac Arrest

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~upto 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and upto 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cerebral oxygenation (rSO2)
Rate of return of spontanueous circulation (ROSC)
Secondary outcome measures
Neurologic outcomes at hospital discharge
short term survival

Trial Design

1Treatment groups
Experimental Treatment
Group I: inhaled nitric oxideExperimental Treatment1 Intervention
Inhaled Nitric Oxide at 40 ppm will be administered in adults who suffer in hospital cardiac arrest. The administration of inhaled nitric oxide at 40 ppm will be provided upto 24 hours once ROSC is achieved.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nitric Oxide
FDA approved

Find a Location

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor
216 Previous Clinical Trials
39,871 Total Patients Enrolled
1 Trials studying Cardiac Arrest
800 Patients Enrolled for Cardiac Arrest
Jignesh K Patel, MDPrincipal InvestigatorStony Brook University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby May 2025